Sakurai Yu, Watanabe Himeka, Nishio Kazuma, Hashimoto Kohei, Harada Atsuki, Gomi Masaki, Suzuki Masayoshi, Oyama Ryotaro, Handa Takumi, Sato Risa, Takeuchi Hina, Taira Ryoga, Tezuka Kenta, Tange Kota, Nakai Yuta, Akita Hidetaka, Uchida Yasuo
Laboratory of DDS Design and Drug Disposition, Graduate School of Pharmaceutical Sciences, Tohoku University, 6-3 Aoba, Aramaki, Aoba-ku, Sendai 980-8578, Japan.
Laboratory of DDS Design and Drug Disposition, Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-0856, Japan.
Pharmaceutics. 2022 Jul 27;14(8):1560. doi: 10.3390/pharmaceutics14081560.
The blood-brain barrier (BBB), which is comprised of brain capillary endothelial cells, plays a pivotal role in the transport of drugs from the blood to the brain. Therefore, an analysis of proteins in the endothelial cells, such as transporters and tight junction proteins, which contribute to BBB function, is important for the development of therapeutics for the treatment of brain diseases. However, gene transfection into the vascular endothelial cells of the BBB is fraught with difficulties, even in vitro. We report herein on the development of lipid nanoparticles (LNPs), in which mRNA is encapsulated in a nano-sized capsule composed of a pH-activated and reductive environment-responsive lipid-like material (ssPalm). We evaluated the efficiency of mRNA delivery into non-polarized human brain capillary endothelial cells, hCMEC/D3 cells. The ssPalm LNPs permitted marker genes (GFP) to be transferred into nearly 100% of the cells, with low toxicity in higher concentration. A proteomic analysis indicated that the ssPalm-LNP had less effect on global cell signaling pathways than a Lipofectamine MessengerMAX/GFP-encoding mRNA complex (LFN), a commercially available transfection reagent, even at higher mRNA concentrations.
血脑屏障(BBB)由脑毛细血管内皮细胞组成,在药物从血液向脑内的转运中起关键作用。因此,分析内皮细胞中的蛋白质,如有助于血脑屏障功能的转运蛋白和紧密连接蛋白,对于开发治疗脑部疾病的疗法至关重要。然而,即使在体外,将基因转染到血脑屏障的血管内皮细胞中也充满困难。我们在此报告脂质纳米颗粒(LNPs)的研发情况,其中的mRNA被包裹在由pH激活和还原环境响应性类脂质材料(ssPalm)组成的纳米胶囊中。我们评估了将mRNA递送至非极化人脑毛细血管内皮细胞hCMEC/D3细胞中的效率。ssPalm LNPs能使标记基因(GFP)转入近100%的细胞,且在较高浓度下毒性较低。蛋白质组学分析表明,即使在较高mRNA浓度下,ssPalm-LNP对整体细胞信号通路的影响也小于市售转染试剂Lipofectamine MessengerMAX/GFP编码mRNA复合物(LFN)。